Provided herein is a combination therapy comprising a compound of Formula (I) and peginterferon alfa 2a or another interferon analog. The combination therapy is useful for the treatment of HBV infection. Also provided herein are compositions comprising a compound of Formula I and peginterferon alfa 2a or another interferon analog.